154 related articles for article (PubMed ID: 36263662)
1. Therapeutic effects of
Yang DM; Cvetkovic D; Chen L; Ma CC
Biomed Phys Eng Express; 2022 Nov; 8(6):. PubMed ID: 36263662
[No Abstract] [Full Text] [Related]
2. Radiodynamic therapy using 15-MV radiation combined with 5-aminolevulinic acid and carbamide peroxide for prostate cancer in vivo.
Panetta JV; Cvetkovic D; Chen X; Chen L; Ma CC
Phys Med Biol; 2020 Aug; 65(16):165008. PubMed ID: 32464613
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Study of the Efficacy and Safety of 5-Aminolevulinic Radiodynamic Therapy for Glioblastoma Fractionated Radiotherapy.
Takahashi J; Nagasawa S; Doi M; Takahashi M; Narita Y; Yamamoto J; Ikemoto MJ; Iwahashi H
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575921
[TBL] [Abstract][Full Text] [Related]
4. Verification of 5-Aminolevurinic Radiodynamic Therapy Using a Murine Melanoma Brain Metastasis Model.
Takahashi J; Nagasawa S; Ikemoto MJ; Sato C; Sato M; Iwahashi H
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31627442
[TBL] [Abstract][Full Text] [Related]
5. ALA-RDT in GBM: protocol of the phase I/II dose escalation trial of radiodynamic therapy with 5-Aminolevulinic acid in patients with recurrent glioblastoma.
Pepper NB; Eich HT; Müther M; Oertel M; Rehn S; Spille DC; Stummer W
Radiat Oncol; 2024 Jan; 19(1):11. PubMed ID: 38254201
[TBL] [Abstract][Full Text] [Related]
6. 5‑aminiolevulinic acid induces a radiodynamic effect with enhanced delayed reactive oxygen species production under hypoxic conditions in lymphoma cells: An
Suzuki K; Yamamoto J; Toh K; Miyaoka R
Exp Ther Med; 2023 Jul; 26(1):360. PubMed ID: 37324514
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of the feasibility of FDG-PET/CT imaging to quantify radiation-induced lung inflammation in locally advanced non-small cell lung cancer patients receiving proton or photon radiotherapy.
Jahangiri P; Pournazari K; Torigian DA; Werner TJ; Swisher-McClure S; Simone CB; Alavi A
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):206-216. PubMed ID: 30229527
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of the Volumetric Parameters of Dual-Time-Point
Okazaki E; Seura H; Hasegawa Y; Okamura T; Fukuda H
AJR Am J Roentgenol; 2019 Dec; 213(6):1366-1373. PubMed ID: 31509426
[No Abstract] [Full Text] [Related]
9. Radiodynamic therapy with CsI(na)@MgO nanoparticles and 5-aminolevulinic acid.
Jiang F; Lee C; Zhang W; Jiang W; Cao Z; Chong HB; Yang W; Zhan S; Li J; Teng Y; Li Z; Xie J
J Nanobiotechnology; 2022 Jul; 20(1):330. PubMed ID: 35842630
[TBL] [Abstract][Full Text] [Related]
10. Assessment of biological parameters in head and neck cancer based on in vivo distribution of
Cegla P; Kazmierska J; Gwozdz S; Czepczynski R; Malicki J; Cholewinski W
Tumori; 2020 Feb; 106(1):33-38. PubMed ID: 31446858
[TBL] [Abstract][Full Text] [Related]
11. The correlation of
Qu YH; Long N; Ran C; Sun J
Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
[TBL] [Abstract][Full Text] [Related]
12. Comparison of dual-time point 18F-FDG PET/CT tumor-to-background ratio, intraoperative 5-aminolevulinic acid fluorescence scale, and Ki-67 index in high-grade glioma.
Kim YI; Cho KG; Jang SJ
Medicine (Baltimore); 2019 Feb; 98(8):e14397. PubMed ID: 30813140
[TBL] [Abstract][Full Text] [Related]
13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
14. Use of
Rudžianskas V; Korobeinikova E; Rudžianskienė M; Jaselskė E; Adlienė D; Šedienė S; Kulakienė I; Padervinskis E; Jurkienė N; Juozaitytė E
Medicina (Kaunas); 2018 Dec; 54(6):. PubMed ID: 30544718
[No Abstract] [Full Text] [Related]
15. Dual-Energy Computed Tomography-Based Iodine Quantitation for Response Evaluation of Lung Cancers to Chemoradiotherapy/Radiotherapy: A Comparison With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Based Positron Emission Tomography/Computed Tomography Response Evaluation Criterion in Solid Tumors.
Ren Y; Jiao Y; Ge W; Zhang L; Hua Y; Li C; Zhai W; Tang X; He W; Fang M; Zheng X
J Comput Assist Tomogr; 2018; 42(4):614-622. PubMed ID: 29613988
[TBL] [Abstract][Full Text] [Related]
16. Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer: A Phase 2 Clinical Trial.
Kong FM; Ten Haken RK; Schipper M; Frey KA; Hayman J; Gross M; Ramnath N; Hassan KA; Matuszak M; Ritter T; Bi N; Wang W; Orringer M; Cease KB; Lawrence TS; Kalemkerian GP
JAMA Oncol; 2017 Oct; 3(10):1358-1365. PubMed ID: 28570742
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis.
Pak K; Kim BS; Kim K; Kim IJ; Jun S; Jeong YJ; Shim HK; Kim SD; Cho KS
Am J Otolaryngol; 2018; 39(1):1-5. PubMed ID: 29056243
[TBL] [Abstract][Full Text] [Related]
18. Predictive and Prognostic Role of Metabolic Response in Patients With Stage III NSCLC Treated With Neoadjuvant Chemotherapy.
Castello A; Toschi L; Rossi S; Finocchiaro G; Grizzi F; Mazziotti E; Qehajaj D; Rahal D; Lopci E
Clin Lung Cancer; 2020 Jan; 21(1):28-36. PubMed ID: 31409523
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effect of combination of hyperthermotherapy and 5-aminolevulinic acid (ALA).
Takahashi K; Hasegawa T; Ishii T; Suzuki A; Nakajima M; Uno K; Yasuda I; Kishi A; Sadamoto K; Abe F; Tanaka T
Anticancer Res; 2013 Jul; 33(7):2861-6. PubMed ID: 23780971
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET/CT and circulating tumor cells in treatment-naive patients with non-small-cell lung cancer.
Zhang F; Wu X; Zhu J; Huang Y; Song X; Jiang L
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3250-3259. PubMed ID: 33630146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
